Tempus AI vs Nabla
A detailed comparison to help you choose between Tempus AI and Nabla.
🏆
Verdict: Tempus AI wins
Tempus AI scores 4.1/5, edging out Nabla at 4.0/5. Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.
Tempus AI AI for precision medicine and clinical genomics | Nabla AI copilot for healthcare professionals | |
|---|---|---|
| Rating | 4.1 (1 review) | 4.0 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $1000/mo | From $99/mo |
| Best For | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. | Individual clinicians, residents and small practices that want an ambient scribe they can evaluate free before any purchase, with a documented no-retention privacy posture. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | ssoteam features | — |
| Visit Tempus AI → | Visit Nabla → |
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Nabla
Pros
- + Genuine free tier — I generated and iterated notes on self-serve signup with no sales call, which almost no clinical AI rival offers
- + Note drafts arrived in under 30 seconds in my tests and respected my chosen template structure rather than transcript order
- + Privacy-first design: audio, transcripts and notes are not retained and patient data is not used for model training, backed by a public trust center (SOC 2 Type 2, ISO 27001, HIPAA, GDPR)
- + Multilingual capture worked in my bilingual French/English test and produced one coherent English note
- + Independent credibility signals: TIME World's Top HealthTech 2026, 85,000+ clinicians and 130+ health organizations reported on nabla.com
Cons
- - No official price list at all — the widely cited ~$119/provider/month Pro figure is third-party-reported, not confirmed by Nabla
- - No diagnostic reasoning, order staging or revenue-cycle depth; coding support is narrower than Suki's HCC/CPT output
- - Free tier caps note volume (third parties report ~30 notes/month) and free users get community-level support only
- - EHR write-back, SSO and tailored models are Enterprise-only, so the workflow payoff needs a sales conversation
- - Ambient attribution slipped with overlapping speakers in my test, requiring manual correction of the draft
Frequently Asked Questions
Which is better, Tempus AI or Nabla?▼
Tempus AI scores higher at 4.1/5 vs 4.0/5 for Nabla, making it the better-rated option in our comparison.
What is the difference between Tempus AI and Nabla?▼
Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties. Nabla: Nabla listens during patient consultations and drafts the clinical note and codes directly into Epic and other electronic health records.
Is Tempus AI or Nabla more affordable?▼
Tempus AI starts at €1000/mo, Nabla starts at €99/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.